Updates on drug discovery in ovarian cancer

Drug discovery in the ovarian cancer arena continues to launch important new clinical trials. Many biologic agents are being studied in phase II and phase III clinical trials for recurrent disease. These agents include compounds that disrupt angiogenesis through a variety of mechanisms. Other oncoge...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibson, Steven J, Tewari, Krishnansu S, Monk, Bradley J, Chase, Dana M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878024/
https://www.ncbi.nlm.nih.gov/pubmed/27231556
http://dx.doi.org/10.1186/2053-6844-1-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878024/
https://www.ncbi.nlm.nih.gov/pubmed/27231556
http://dx.doi.org/10.1186/2053-6844-1-3

Ejemplares similares